Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Distribution of Type 2 biomarkers and association with severity, clinical characteristics and co-morbidities in the BREATHE real-life asthma population

Laurits Frøssing, Ditte K Klein, Morten Hvidtfeldt, Nicolai Obling, Gunilla Telg, Jonas S Erjefält, Uffe Bodtger, Celeste Porsbjerg
ERJ Open Research 2022; DOI: 10.1183/23120541.00483-2022
Laurits Frøssing
1Respiratory Research Unit, Department of Respiratory Medicine, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark
6Contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: froessing@dadlnet.dk
Ditte K Klein
1Respiratory Research Unit, Department of Respiratory Medicine, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark
6Contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Morten Hvidtfeldt
1Respiratory Research Unit, Department of Respiratory Medicine, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Morten Hvidtfeldt
Nicolai Obling
2Respiratory Research Unit PLUZ, Department of Respiratory Medicine; Zealand University Hospital Naestved, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicolai Obling
Gunilla Telg
3Astrazeneca Nordic, Södertälje, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonas S Erjefält
4Unit of Airway Inflammation, Lund University, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Uffe Bodtger
2Respiratory Research Unit PLUZ, Department of Respiratory Medicine; Zealand University Hospital Naestved, Denmark
5Institute of Regional Health Research, University of Southern Denmark, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Celeste Porsbjerg
1Respiratory Research Unit, Department of Respiratory Medicine, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1183/23120541.00483-2022

Published By 
European Respiratory Society
Online ISSN 
2312-0541
History 
  • Received September 19, 2022
  • Accepted September 30, 2022
  • Published online October 27, 2022.

Copyright & Usage 
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org

Author Information

  1. Laurits Frøssing1,6⇑,
  2. Ditte K Klein1,6,
  3. Morten Hvidtfeldt1,
  4. Nicolai Obling2,
  5. Gunilla Telg3,
  6. Jonas S Erjefält4,
  7. Uffe Bodtger2,5 and
  8. Celeste Porsbjerg1
  1. 1Respiratory Research Unit, Department of Respiratory Medicine, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark
  2. 2Respiratory Research Unit PLUZ, Department of Respiratory Medicine; Zealand University Hospital Naestved, Denmark
  3. 3Astrazeneca Nordic, Södertälje, Sweden
  4. 4Unit of Airway Inflammation, Lund University, Sweden
  5. 5Institute of Regional Health Research, University of Southern Denmark, Denmark
  6. 6Contributed equally
  1. Corresponding author: Laurits Frøssing (froessing{at}dadlnet.dk)
View Full Text

Funding

  • Teva Pharmaceutical Industries

    Unrestricted grant
  • Interreg Öresund-Kattegat-Skagerrak

    NYPS20201002
  • AstraZeneca

    Unrestricted grant

Article usage

Article usage: October 2022 to December 2022

AbstractFullPdf
Oct 2022185115
Nov 2022647545
Dec 20229176

Altmetrics

PreviousNext
Back to top
Vol 9 Issue 1 Table of Contents
ERJ Open Research: 9 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Distribution of Type 2 biomarkers and association with severity, clinical characteristics and co-morbidities in the BREATHE real-life asthma population
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Distribution of Type 2 biomarkers and association with severity, clinical characteristics and co-morbidities in the BREATHE real-life asthma population
Laurits Frøssing, Ditte K Klein, Morten Hvidtfeldt, Nicolai Obling, Gunilla Telg, Jonas S Erjefält, Uffe Bodtger, Celeste Porsbjerg
ERJ Open Research Jan 2022, 00483-2022; DOI: 10.1183/23120541.00483-2022

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Distribution of Type 2 biomarkers and association with severity, clinical characteristics and co-morbidities in the BREATHE real-life asthma population
Laurits Frøssing, Ditte K Klein, Morten Hvidtfeldt, Nicolai Obling, Gunilla Telg, Jonas S Erjefält, Uffe Bodtger, Celeste Porsbjerg
ERJ Open Research Jan 2022, 00483-2022; DOI: 10.1183/23120541.00483-2022
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Delineating associations of progressive pleuroparenchymal fibroelastosis in patients with pulmonary fibrosis
  • Incidence of cognitive impairment and dementia after hospitalisation for pneumonia: a UK population-based matched cohort study
  • Validation of the HULL Score clinical prediction rule (CPR) for unsuspected pulmonary embolism in ambulatory cancer patients
Show more Original research article

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society